// Chartbeat tag // Chartbeat tag

Invacare signs consent decree to correct wheelchair manufacturing problems

Share this article:


Invacare has signed a consent decree in which the company will fix wheelchair manufacturing problems, the Food and Drug Administration announced. Specifically,  the decree limits the production of custom power and manual wheelchairs, wheelchair components and wheelchair subassemblies at one of the firm's manufacturing plants. The decree also limits design activities related to wheelchairs and power beds at the Elyria operations. All other Invacare facilities remain in full operation. Invacare said the consent decree is subject to approval of the U.S. District Court for the Northern District of Ohio.

Share this article:

More in Products

Higher rates of mortality seen with benzodiazepine sedatives, study says

Continuous infusion benzodiazepines, a group of sedatives often used to treat intensive-care unit patients on ventilators, are linked to an increased likelihood of death compared to those who received propofol, a new study says.

Drive Medical introduces long-term care beds

Drive Medical introduces long-term care beds

Drive Medical is offering four new long-term care beds, including two models designed with the bariatric resident in mind.

New footwear sanitizing system released

New footwear sanitizing system released

Best Sanitizers Inc. has announced the HACCP SmartStep™ Footwear Sanitizing System. The system reduces cross-contamination from footwear for employees working in labs, clean rooms or in pharmaceutical plants.